ATE343384T1 - Pharmazeutische zusammensetzungen enthaltend aminothiazole derivate zur behandlung von motorischen störungen des dickdarms - Google Patents

Pharmazeutische zusammensetzungen enthaltend aminothiazole derivate zur behandlung von motorischen störungen des dickdarms

Info

Publication number: ATE343384T1
Authority: AT; Austria
Prior art keywords: treatment; pharmaceutical compositions; compositions containing; aminothiazole derivatives; motor disorders
Prior art date: 2000-09-08

Application number

AT01930024T

Other languages

English (en)

Inventor

Shigeru Ueki

Yuko Hori

Yugo Matsunaga

Masaaki Nagasawa

Hiroyasu Nishioka

Masakazu Murata

Original Assignee

Zeria Pharm Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-08

Filing date

2001-05-10

Publication date

2006-11-15

2001-05-10 Application filed by Zeria Pharm Co Ltd filed Critical Zeria Pharm Co Ltd

2006-11-15 Application granted granted Critical

2006-11-15 Publication of ATE343384T1 publication Critical patent/ATE343384T1/de

Links

RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical class NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 title abstract 2
208000019430 Motor disease Diseases 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
206010061296 Motor dysfunction Diseases 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 2
230000000112 colonic effect Effects 0.000 abstract 2
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
206010010774 Constipation Diseases 0.000 abstract 1
206010021333 Ileus paralytic Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
210000005036 nerve Anatomy 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT01930024T 2000-09-08 2001-05-10 Pharmazeutische zusammensetzungen enthaltend aminothiazole derivate zur behandlung von motorischen störungen des dickdarms ATE343384T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2000273025		2000-09-08

Publications (1)

Publication Number	Publication Date
ATE343384T1 true ATE343384T1 (de)	2006-11-15

Family

ID=18759044

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01930024T ATE343384T1 (de)	2000-09-08	2001-05-10	Pharmazeutische zusammensetzungen enthaltend aminothiazole derivate zur behandlung von motorischen störungen des dickdarms

Country Status (14)

Country	Link
US (1)	US6673368B2 (de)
EP (1)	EP1315488B1 (de)
JP (1)	JP4876367B2 (de)
KR (1)	KR100776298B1 (de)
CN (1)	CN1264512C (de)
AT (1)	ATE343384T1 (de)
AU (2)	AU2001256685B2 (de)
CA (1)	CA2419666C (de)
DE (1)	DE60124117T8 (de)
DK (1)	DK1315488T3 (de)
ES (1)	ES2273838T3 (de)
PT (1)	PT1315488E (de)
TW (1)	TWI296522B (de)
WO (1)	WO2002020010A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2301540A1 (de) *	2002-04-08	2011-03-30	Zeria Pharmaceutical Co., Ltd.	Therapeutisches Mittel für beeinträchtigte Magenakkommodation
SG182849A1 (en)	2003-04-25	2012-08-30	Gilead Sciences Inc	Antiviral phosphonate analogs
PT2258376T (pt)	2004-07-27	2019-05-31	Gilead Sciences Inc	Análogos fosfonatados de compostos inibidores do vih
CA2580725A1 (en) *	2004-09-20	2006-03-30	4Sc Ag	Novel heterocyclic nf-kb inhibitors
KR100670974B1 (ko) *	2006-09-18	2007-02-28	(주) 리드제넥스	티아졸 유도체의 조합화학적 방법에 의한 분자다양성구축기술
BRPI0915878A2 (pt)	2008-07-08	2015-11-03	Gilead Sciences Inc	sais ou hidratos de compostos inibidores de hiv, seu uso e composição farmacêutica que os compreende
JP5885738B2 (ja) *	2011-04-13	2016-03-15	オリンパス株式会社	単一発光粒子検出を用いた光分析装置、光分析方法及び光分析用コンピュータプログラム
CN104130207B (zh) *	2014-07-07	2016-08-24	湖北华世通生物医药科技有限公司	阿考替胺氢溴酸盐水合物及其晶型的制备方法
PT3661937T (pt)	2017-08-01	2021-09-24	Gilead Sciences Inc	Formas cristalinas de ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-il)-4-fluoro-2,5-dihidrofurano-2-il)oxi)metil)(fenoxi)fosforil)-l-alaninato de etil (gs-9131) para tratamento de infeções virais

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2134229A1 (en)	1992-05-12	1993-11-13	Osamu Kitagawa	Novel quaternary ammonium salts and use thereof as medicine
CN1063442C (zh) *	1995-05-18	2001-03-21	泽里新药工业株式会社	氨基噻唑衍生物、含有它们的药物组合物及其用途
AU717588B2 (en)	1996-10-24	2000-03-30	Zeria Pharmaceutical Co., Ltd.	Substituted benzoylaminothiazole derivative and medicament containing the same
JPH10212271A (ja) *	1997-01-31	1998-08-11	Zeria Pharmaceut Co Ltd	Ｎ−置換ベンゾイルアミン誘導体、それを含有する医薬及び該化合物の製造中間体
DK0994108T3 (da)	1997-06-24	2003-08-18	Zeria Pharm Co Ltd	Fremgangsmåde til fremstilling af 2-hydroxybenzamidderivater

2001
- 2001-05-10 JP JP2002524494A patent/JP4876367B2/ja not_active Expired - Lifetime
- 2001-05-10 CN CNB018153046A patent/CN1264512C/zh not_active Expired - Fee Related
- 2001-05-10 DE DE60124117T patent/DE60124117T8/de active Active
- 2001-05-10 PT PT01930024T patent/PT1315488E/pt unknown
- 2001-05-10 CA CA002419666A patent/CA2419666C/en not_active Expired - Fee Related
- 2001-05-10 EP EP01930024A patent/EP1315488B1/de not_active Expired - Lifetime
- 2001-05-10 KR KR1020037002981A patent/KR100776298B1/ko not_active Expired - Fee Related
- 2001-05-10 AU AU2001256685A patent/AU2001256685B2/en not_active Ceased
- 2001-05-10 ES ES01930024T patent/ES2273838T3/es not_active Expired - Lifetime
- 2001-05-10 AT AT01930024T patent/ATE343384T1/de active
- 2001-05-10 WO PCT/JP2001/003893 patent/WO2002020010A1/en not_active Ceased
- 2001-05-10 TW TW090111395A patent/TWI296522B/zh not_active IP Right Cessation
- 2001-05-10 AU AU5668501A patent/AU5668501A/xx active Pending
- 2001-05-10 DK DK01930024T patent/DK1315488T3/da active
- 2001-05-14 US US09/853,746 patent/US6673368B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US20020051805A1 (en)	2002-05-02
JP2004508328A (ja)	2004-03-18
DK1315488T3 (da)	2007-02-12
PT1315488E (pt)	2007-01-31
EP1315488B1 (de)	2006-10-25
US6673368B2 (en)	2004-01-06
ES2273838T3 (es)	2007-05-16
AU2001256685B2 (en)	2005-12-22
JP4876367B2 (ja)	2012-02-15
EP1315488A2 (de)	2003-06-04
KR20030029881A (ko)	2003-04-16
CN1264512C (zh)	2006-07-19
TWI296522B (en)	2008-05-11
CN1460020A (zh)	2003-12-03
DE60124117T2 (de)	2007-02-15
AU5668501A (en)	2002-03-22
KR100776298B1 (ko)	2007-11-13
DE60124117T8 (de)	2007-05-31
DE60124117D1 (de)	2006-12-07
WO2002020010A1 (en)	2002-03-14
CA2419666C (en)	2009-10-27
CA2419666A1 (en)	2003-02-26

Similar Documents

Publication	Publication Date	Title
MY130668A (en)	2007-07-31	Isothiazole derivatives useful as anticancer agents
HUP0402310A2 (hu)	2005-02-28	1,6-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények
MX9702865A (es)	1998-05-31	Agentes estrogenicos.
EP1070710A3 (de)	2001-03-21	Dithiolan Derivate, deren Herstellung und deren therapeutischer Wirkung
HUP0100266A2 (hu)	2002-05-29	NMDA-receptor-antagonista hatású 1-aminoalkilciklohexánszármazékok, a vegyületeket tartalmazó gyógyszerkészítmények és előállításaik
WO2003080580A3 (en)	2004-02-05	Quinoline derivatives and their use as 5-ht6 ligands
WO2005030766A8 (en)	2006-03-02	Phenyl - carboxamide compounds useful for treating pain
MXPA04000577A (es)	2004-04-20	Derivados de dolastatina 10.
BRPI0406801A (pt)	2006-01-17	Derivados de tieno-pirimidinodiona e uso dos mesmos na modulação de doenças autoimunes
PT828728E (pt)	2003-06-30	Di-hidrobenzofuranos de fenilo
TW200510317A (en)	2005-03-16	Caspase inhibitors and uses thereof
ATE312815T1 (de)	2005-12-15	Neue verbindungen
DE60124117D1 (de)	2006-12-07	Pharmazeutische zusammensetzungen enthaltend aminothiazole derivate zur behandlung von motorischen störungen des dickdarms
RU94036745A (ru)	1996-12-10	Производные галантамина и фармацевтическая композиция
AP2001002191A0 (en)	2001-06-01	3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
UA50711C2 (uk)	2002-11-15	Антрациклінові похідні, їх застосування при лікуванні амілоїдозу та фармацевтична композиція
CA2423007A1 (en)	2003-03-24	Spiro derivatives and adhesion molecule inhibitors containing the same as effective ingredients
AP9801377A0 (en)	2000-04-29	Tricyclic erythromycin derivatives.
DE69933885D1 (de)	2006-12-14	Triphenylbutenderivate zur behandlung von neurologischen störungen
HK1046404A1 (zh)	2003-01-10	用作nmda受体拮抗剂的取代的吡咯烷-2，3，4-三酮-3-肟衍生物
ATE239711T1 (de)	2003-05-15	Neue allythiopyridazinderivate und verfahren zu ihrer herstellung
ATE161178T1 (de)	1998-01-15	Pyrazolpyridine für die behandlung der anämie
ATE437636T1 (de)	2009-08-15	Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen
BR9604907A (pt)	1998-07-21	Derivados de nucleosideos hamocarbociclico de pirimidinodiona substituida aniviral e métodos de preparo dos mesmos e composiçoes contendo tais derivados como principios ativos
EA200201024A1 (ru)	2003-02-27	Фармацевтические композиции, содержащие олигосахариды, и их получение

Legal Events

Date

Code

Title

Description

2007-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1315488

Country of ref document: EP